Group One Trading’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-49,675
| Closed | -$370K | – | 8113 |
|
|
2023
Q4 | $370K | Hold |
49,675
| – | – | ﹤0.01% | 3326 |
|
|
2023
Q3 | $481K | Hold |
49,675
| – | – | ﹤0.01% | 2951 |
|
|
2023
Q2 | $509K | Hold |
49,675
| – | – | ﹤0.01% | 2999 |
|
|
2023
Q1 | $519K | Sell |
49,675
-93,800
| -65% | -$1.25M | ﹤0.01% | 2749 |
|
|
2022
Q4 | $1.84M | Sell |
143,475
-1,000
| -0.7% | -$14.8K | ﹤0.01% | 1899 |
|
|
2022
Q3 | $2.25M | Buy |
144,475
+138,638
| +2,375% | +$2.66M | ﹤0.01% | 1806 |
|
|
2022
Q2 | $115K | Sell |
5,837
-1
| -0% | -$25 | ﹤0.01% | 4854 |
|
|
2022
Q1 | $213K | Sell |
5,838
-3
| -0.1% | -$108 | ﹤0.01% | 4732 |
|
|
2021
Q4 | $208K | Buy |
5,841
+3,798
| +186% | +$200K | ﹤0.01% | 5052 |
|
|
2021
Q3 | $153K | Buy |
2,043
+1,312
| +179% | +$93.2K | ﹤0.01% | 5453 |
|
|
2021
Q2 | $64K | Buy |
731
+540
| +283% | +$51.4K | ﹤0.01% | 6366 |
|
|
2021
Q1 | $22K | Buy |
+191
| New | +$21.2K | ﹤0.01% | 6729 |
|
|
2019
Q3 | – | Sell |
-83
| Closed | -$24K | – | 5632 |
|
|
2019
Q2 | $24K | Buy |
83
+50
| +152% | +$17.6K | ﹤0.01% | 4110 |
|
|
2019
Q1 | $15K | Buy |
+33
| New | +$12.8K | ﹤0.01% | 4138 |
|
|
2018
Q2 | – | Sell |
-50
| Closed | -$7K | – | 5548 |
|
|
2018
Q1 | $7K | Sell |
50
-2
| -4% | -$391 | ﹤0.01% | 4435 |
|
|
2017
Q4 | $12K | Buy |
52
+26
| +100% | +$5.41K | ﹤0.01% | 4332 |
|
|
2017
Q3 | $5K | Buy |
+26
| New | +$4.79K | ﹤0.01% | 4499 |
|
|
2017
Q2 | – | Sell |
-105
| Closed | -$32K | – | 5160 |
|
|
2017
Q1 | $32K | Sell |
105
-12
| -10% | -$3.53K | ﹤0.01% | 3658 |
|
|
2016
Q4 | $42K | Buy |
+117
| New | +$43.6K | ﹤0.01% | 3355 |
|
Other funds holding CSCI
Group One Trading's CSCI Position: Q3 2025 in Review
Group One Trading sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 37 shares — an estimated $125 sold.
Group One Trading first reported a position in CSCI in Q2 2016 and held it in 21 quarters. The position peaked at $272K in Q3 2016. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.
- Group One Trading reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
- Group One Trading sold 37 COSCIENS Biopharma Inc. Common Stock shares in Q3 2025, an estimated $125.
- Group One Trading first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2016 and held it in 21 quarters.
- Group One Trading's COSCIENS Biopharma Inc. Common Stock position peaked at $272K in Q3 2016.
- 2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.
Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.